全球新生兒加護治療呼吸設備市場規模（按設備類型、最終用戶、區域範圍和預測）

新生兒加護治療呼吸設備市場規模及預測

2024 年新生兒加護治療呼吸設備市場規模價值 137.2 億美元，預計到 2032 年將達到 178.2 億美元，預測期內（2026-2032 年）的複合年成長率為 3.66%。

新生兒加護治療呼吸設備是一種專門的醫療設備，旨在支持早產和危重新生兒的呼吸。這些設備包括人工呼吸器、持續性陽壓呼吸器(CPAP) 機和氧氣輸送系統。

新生兒加護治療呼吸設備對於新生兒加護病房(NICU) 處理新生兒呼吸窘迫至關重要。 新生兒加護呼吸設備對於新生兒加護病房(NICU) 處理加護治療呼吸窘迫至關重要。

這些設備為患有呼吸窘迫症候群、早產兒呼吸暫停和支氣管肺發育不良等疾病的新生兒提供關鍵的呼吸支持，有助於支持肺功能和穩定呼吸模式，從而改善高風險新生兒的整體預後。

預期的技術改進將提升新生兒加護治療呼吸設備的效率和功能，從而改善臨床療效。先進監測和自動化功能的整合將推動下一代設備的發展，確保為新生兒提供更優質的照護。

新生兒加護治療呼吸設備的全球市場動態

影響全球新生兒加護治療呼吸設備市場的關鍵市場動態是：

關鍵市場促進因素

早產率上升：全球早產率上升是新生兒呼吸設備市場的主要驅動力。早產兒通常肺部發育不良，需要使用專門的呼吸支持設備，例如持續陽壓呼吸器(CPAP) 系統和機械人工呼吸器來幫助他們呼吸。早產兒對呼吸支援的需求不斷成長，凸顯了先進呼吸支援設備在新生兒護理中的關鍵作用。

呼吸窘迫症候群 (RDS) 意識的提升：呼吸窘迫症候群 (RDS) 是新生兒最常見的肺部疾病，也是新生兒加護病房(NICU) 的主要死亡原因，人們對該疾病的認知日益加深，這推動了對先進呼吸設備解決方案的需求。隨著醫護人員和家長對 RDS 的了解日益加深，人們越來越重視獲得有效可靠的呼吸設備來管理和治療該疾病。

技術進步：該領域的技術創新推動了監測能力的增強、非侵入性通氣技術的進步以及微型化設計的發展，從而提高了患者的舒適度。這些技術改進不僅提高了新生兒呼吸照護的有效性，也讓設備更容易使用，更能滿足新生兒的細微需求。

微創手術：新生兒照護中微創手術的趨勢也是推動先進呼吸設備普及的關鍵因素。微創手術旨在減少患者不適和併發症風險。與傳統機械通氣相比，高流量氧氣鼻管(HFNC) 和氣泡持續性正壓呼吸器 (CPAP) 系統等設備提供的呼吸支持侵入性更低，因此在新生兒護理中越來越受歡迎。

政府措施與報銷：政府措施和支持性報銷措施在推動新生兒呼吸設備市場成長方面發揮關鍵作用。改善新生兒醫療基礎設施的努力，加上優惠的呼吸設備報銷框架，正在提高獲得先進新生兒護理的可及性。這些政府支持的措施使醫院和診所能夠提供最先進的呼吸支援技術，從而改善需要呼吸支持的新生兒的預後。

主要問題

嚴格的監管：監管新醫療設備核准的嚴格法律規範也可能阻礙市場准入，並減緩新生兒患者獲得先進呼吸設備技術的速度。雖然此類監管對於確保患者安全和設備有效性至關重要，但它們也可能減緩創新解決方案的引入。如何在嚴格的安全標準與新技術的快速部署之間取得平衡，仍然是監管機構和製造商共同關注的關鍵問題。

熟練勞動力短缺：缺乏經過培訓、能夠操作和維護先進新生兒呼吸設備的熟練醫療保健專業人員。這些先進設備需要專門的訓練和專業知識才能有效使用。在缺乏訓練有素人員的地區，這些技術的潛在優勢可能無法充分發揮，從而限制其對新生兒護理的影響。

院內感染的風險：新生兒加護病房 (NICU) 的新生兒特別容易感染院內感染（簡稱「院內感染」）。如果不遵守適當的消毒和感染控制規程，使用呼吸設備會增加這些感染疾病的風險。確保呼吸設備嚴格衛生並定期維護，對於最大限度地降低感染疾病風險和保護脆弱患者的健康至關重要。

新興國家供應有限：在新興國家，先進的新生兒呼吸設備價格高昂，且缺乏訓練有素的醫護人員，是取得這些設備的主要障礙。這些因素造成了救生技術在可及性和應用方面的差距，凸顯了製定具有成本效益的解決方案和旨在建立當地能力的舉措的必要性。應對這些挑戰需要多管齊下的方法，包括開發價格合理的設備、​​投資培訓項目以及開展國際合作，以支持資源匱乏地區的醫療基礎設施建設。

主要趨勢

早期發現和早期療育：新生兒呼吸窘迫的早期診斷和早期療育對於改善預後至關重要。目前的趨勢是開發能夠持續監測和早期發現呼吸窘迫的設備。這種先進的監測系統旨在快速發現呼吸窘迫問題的徵兆，使醫護人員能夠更快、更有效地介入。早期檢測技術有助於預防併發症，改善呼吸窘迫新生兒的整體預後，確保及時、適當的照護。

遠端醫療整合：將遠端醫療解決方案整合到新生兒呼吸照護中，正在改變照護的提供方式，尤其是在新生兒加護病房(NICU) 有限的地區。遠端醫療可以實現遠端監控並與專家會診，從而彌合患者與專家護理之間的差距。利用遠端醫療，醫療服務提供者可以提供即時支援和指導，從而提高偏遠和服務欠缺地區的新生兒護理品質。這種整合不僅提高了專科護理的可近性，還支持持續監測，以便及時處理徵兆。

家庭呼吸支持：科技進步推動了為病情穩定的新生兒提供家庭呼吸支持的日益成長的趨勢。這種轉變需要開發適合家庭環境的攜帶式、易於使用的設備。家庭呼吸支援使父母能夠在熟悉的環境中照顧新生兒，從而減少住院時間和相關費用。這些可攜式設備設計易於使用，使父母能夠有效安全地在家中管理嬰兒的呼吸支持，同時在需要時仍能獲得專家支持。

患者舒適度和活動能力：最大限度地減少患者不適並促進活動能力是新生兒護理的關鍵考慮因素。新趨勢著重於開發能夠允許患者更大活動範圍並最大程度減少限制的呼吸設備。這些創新旨在透過減少呼吸支持方法的侵入性並允許更自然的活動來提高新生兒的舒適度。提高患者的活動能力已成為現代新生兒呼吸護理的重要方面，因為它不僅有助於促進身體發育，還能提升整體健康水平。

整合人工智慧：人工智慧 (AI) 有望透過提供先進的數據分析和決策支持，徹底改變新生兒呼吸護理。 AI 演算法可以分析大量患者數據，識別呼吸模式並預測潛在的呼吸問題，從而為臨床醫生提供最佳呼吸支持策略的洞察。利用 AI 可以幫助醫療保健提供者做出更明智的決策，制定個人化治療方案，並可能改善呼吸系統疾病新生兒的預後。 AI 與呼吸照護系統的整合，代表著新生兒照護準確性和有效性的重大飛躍。

注重永續性：人們越來越重視開發環保節能的新生兒呼吸設備。這種對永續性的關注旨在促進負責任的資源管理並長期降低成本。製造商正在探索開發環境影響較小的設備的方法，包括使用可回收材料和設計更節能的系統。這些努力不僅支持全球永續性目標，還能降低醫療機構的營運成本，讓先進的呼吸照護更容易取得且價格更實惠。

目錄

第 1 章全球新生兒加護治療呼吸設備市場簡介

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章新生兒加護治療呼吸設備的全球市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

5. 全球新生兒加護治療呼吸設備市場（依設備類型）

• 概述
• 噴霧器
• 吸入器
• 人工呼吸器設備
• 持續性氣道正壓通氣裝置
• 呼吸暫停監測器
• 其他

6. 全球新生兒加護治療呼吸設備市場（依最終用戶）

• 概述
• 新生兒加護病房
• 專科診所
• 養老院
• 其他

7. 全球新生兒加護治療呼吸設備市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 其他
  • 拉丁美洲
  • 中東和非洲

8. 全球新生兒加護治療呼吸設備市場的競爭格局

• 概述
• 各公司市場排名
• 重點發展策略

第9章 公司簡介

• Getinge AB
• GE Healthcare
• Vyaire Medical Inc.（BD）
• Teleflex Incorporated
• Medtronic plc
• Mercury Medical
• Dragerwerk AG & Co. KGaA
• Dickinson & Company
• Inspiration Healthcare Group plc
• Trudell Medical International

第10章 重大進展

• 產品發布/開發
• 合併與收購
• 業務擴展
• 夥伴關係與合作

第11章 附錄

• 相關調查

Neonatal Intensive Care Respiratory Devices Market Size And Forecast

The Neonatal Intensive Care Respiratory Devices Market size was valued to be USD 13.72 Billion in the year 2024 and it is expected to reach USD 17.82 Billion in 2032, at a CAGR of 3.66% over the forecast period of 2026 to 2032.

Specialized medical equipment known as neonatal intensive care respiratory devices are designed to support the respiratory function of premature and critically ill newborns. Included in these devices are ventilators, continuous positive airway pressure (CPAP) machines, and oxygen delivery systems.

Essential utilization of neonatal intensive care respiratory devices occurs in neonatal intensive care units (NICUs) for managing respiratory distress in newborns. Adequate oxygenation and ventilation support are ensured for infants during critical periods through the implementation of these devices.

Vital respiratory assistance is provided by these devices to neonates experiencing conditions such as respiratory distress syndrome, apnea of prematurity, and bronchopulmonary dysplasia. Support for lung function and stabilization of breathing patterns is facilitated, leading to improved overall outcomes for at-risk infants.

Anticipated enhancements in technology are expected to improve the efficiency and functionality of neonatal intensive-care respiratory devices, leading to better clinical outcomes. Integration of advanced monitoring and automation features is likely to drive the development of next-generation devices, ensuring superior care for neonates.

Global Neonatal Intensive Care Respiratory Devices Market Dynamics

The key market dynamics that are shaping the global neonatal intensive care respiratory devices market include:

Key Market Drivers:

Rising Preterm Births: The rising incidence of preterm births globally is a significant driver for the neonatal respiratory devices market. Premature infants often have underdeveloped lungs, necessitating the use of specialized respiratory support devices such as bubble continuous positive airway pressure (CPAP) systems and mechanical ventilators to assist their breathing. This growing need for respiratory assistance in preterm newborns underscores the critical role of advanced respiratory devices in neonatal care.

Growing Awareness of RDS: Increased awareness of respiratory distress syndrome (RDS), the most common lung disorder in newborns and a leading cause of mortality in neonatal intensive care units (NICUs), further fuels demand for advanced respiratory solutions. As healthcare providers and parents become more informed about RDS, there is a heightened emphasis on obtaining effective and reliable respiratory devices to manage and treat this condition.

Technological Advancements: Innovations in this field have resulted in devices with enhanced monitoring capabilities, non-invasive ventilation techniques, and miniaturized designs that improve patient comfort. These technological improvements not only enhance the effectiveness of neonatal respiratory care but also ensure that the devices are easier to use and more adaptable to the delicate needs of newborns.

Minimally Invasive Procedures: The trend towards minimally invasive procedures in neonatal care is another key factor driving the adoption of advanced respiratory devices. Minimally invasive techniques aim to reduce patient discomfort and the risk of complications. Devices such as high-flow nasal cannula (HFNC) and bubble CPAP systems offer less invasive respiratory support compared to traditional mechanical ventilation, making them increasingly popular choices in neonatal care settings.

Government Initiatives and Reimbursement: Government initiatives and supportive reimbursement policies play a crucial role in driving the growth of the neonatal respiratory devices market. Efforts to improve neonatal healthcare infrastructure, coupled with favorable reimbursement frameworks for respiratory devices, enhance accessibility to advanced neonatal care. These government-supported initiatives ensure that hospitals and clinics can provide state-of-the-art respiratory support technologies, thereby improving outcomes for newborns requiring respiratory assistance.

Key Challenges:

Stringent Regulations: Stringent regulatory frameworks governing the approval of new medical devices can also impede market entry and delay the availability of advanced respiratory technologies for newborns. While these regulations are essential for ensuring patient safety and device efficacy, they can slow down the introduction of innovative solutions. Balancing the need for rigorous safety standards with the rapid deployment of new technologies remains a critical consideration for regulatory bodies and manufacturers alike.

Skilled Workforce Shortages: Lack of skilled healthcare professionals trained to operate and maintain sophisticated neonatal respiratory devices. The effective use of these advanced devices requires specialized training and expertise. In regions where there is a lack of trained personnel, the potential benefits of these technologies may not be fully realized, limiting their impact on neonatal care.

Nosocomial Infection Risk: Neonates in NICUs are particularly vulnerable to nosocomial, or hospital-acquired, infections. The use of respiratory devices increases the risk of these infections if proper sterilization and infection control protocols are not strictly followed. Ensuring rigorous hygiene practices and regular maintenance of respiratory equipment is crucial to minimizing the risk of infections and safeguarding the health of these vulnerable patients.

Limited Availability in Developing Countries: In developing countries, the high cost of advanced neonatal respiratory devices and the scarcity of trained healthcare personnel present substantial barriers to access. These factors contribute to a disparity in the availability and utilization of life-saving technologies, highlighting the need for cost-effective solutions and initiatives aimed at building local capacity. Addressing these challenges requires a multifaceted approach, including the development of affordable devices, investment in training programs, and international collaboration to support healthcare infrastructure in low-resource settings.

Key Trends:

Early Detection and Intervention: Early diagnosis and intervention for respiratory problems in newborns are crucial for improving outcomes. Current trends focus on the development of devices that provide continuous monitoring and early detection of respiratory distress. These advanced monitoring systems are designed to promptly identify signs of respiratory issues, allowing healthcare providers to intervene more quickly and effectively. Early detection technologies can help prevent complications and improve the overall prognosis for neonates with respiratory challenges, ensuring timely and appropriate care.

Telemedicine Integration: Integrating telemedicine solutions with neonatal respiratory care is transforming how care is delivered, particularly in regions with limited access to neonatal intensive care units (NICUs). Telemedicine enables remote monitoring and consultations with specialists, bridging the gap between patients and expert care. By utilizing telemedicine, healthcare providers can offer real-time support and guidance, improving the quality of care for newborns in remote or underserved areas. This integration not only enhances access to specialized care but also supports continuous monitoring, ensuring that any signs of distress are addressed promptly.

Home-Based Respiratory Support: Technological advancements are driving a growing trend toward providing home-based respiratory support for stable neonates. This shift requires the development of portable and user-friendly devices suitable for home settings. Home-based respiratory support allows parents to care for their infants in a familiar environment, which can reduce hospital stays and associated costs. These portable devices are designed to be easy to use, ensuring that parents can manage their infants' respiratory needs effectively and safely at home, while still having access to professional medical support when needed.

Patient Comfort and Mobility: Minimizing patient discomfort and promoting mobility are essential considerations in neonatal care. New trends focus on developing respiratory devices that allow for greater patient movement and minimize restrictions. These innovations aim to enhance the comfort of neonates by reducing the invasiveness of respiratory support methods and allowing for more natural movement. Improved patient mobility not only contributes to better physical development but also enhances overall well-being, making it a critical aspect of modern neonatal respiratory care.

AI Integration: Artificial intelligence (AI) is poised to revolutionize neonatal respiratory care by offering advanced data analysis and decision-making support. AI algorithms can analyze vast amounts of patient data to identify patterns and predict potential respiratory issues, providing clinicians with insights into optimal respiratory support strategies. By leveraging AI, healthcare providers can make more informed decisions, personalize treatment plans, and potentially improve outcomes for neonates with respiratory conditions. The integration of AI into respiratory care systems represents a significant leap forward in the precision and effectiveness of neonatal care.

Sustainability Focus: There is an increasing emphasis on developing environmentally friendly and energy-efficient neonatal respiratory devices. This sustainability focus aims to promote responsible resource management and cost reduction in the long term. Manufacturers are exploring ways to create devices that have a lower environmental impact, such as using recyclable materials and designing energy-efficient systems. These efforts not only support global sustainability goals but also reduce operational costs for healthcare facilities, making advanced respiratory care more accessible and affordable.

Global Neonatal Intensive Care Respiratory Devices Market Regional Analysis

Here is a more detailed regional analysis of the global neonatal intensive care respiratory devices market:

North America:

North America is substantially dominating the Global Neonatal Intensive Care Respiratory Devices Market and is expected to continue its dominance throughout the forecast period.

North America is a leader in the neonatal respiratory devices market, thanks to its advanced healthcare infrastructure, which includes a high concentration of specialized neonatal intensive care units (NICUs) equipped with cutting-edge respiratory devices.

The region experiences a relatively high rate of preterm births, which significantly increases the demand for respiratory support for neonates.

Efforts to prevent preterm births are ongoing, yet advancements in neonatal care have notably improved the survival rates of premature infants, further necessitating the need for sophisticated respiratory aid.

Supportive government policies and robust healthcare reimbursement systems play a crucial role in ensuring hospitals have access to the latest respiratory technologies. These policies facilitate the procurement of advanced devices, enhancing the quality of neonatal care.

Furthermore, North America's status as a hub for medical research and development fosters the creation of innovative neonatal respiratory devices, keeping the region at the forefront of technological advancements in healthcare.

The market dynamics in North America are characterized by high adoption rates of new and advanced neonatal respiratory devices, driven by the region's focus on technological innovation and improving neonatal outcomes.

There is a growing preference for minimally invasive respiratory support options, such as High Flow Nasal Cannula (HFNC), which are designed to minimize discomfort for neonates while providing effective respiratory assistance.

The presence of major companies like Philips, ResMed, and GE Healthcare dominates the North American market, driving continuous innovation and competition. These key players' commitment to developing advanced, user-friendly, and minimally invasive respiratory solutions ensures that North America remains a leader in the neonatal respiratory devices market.

Asia Pacific

The Asia Pacific (APAC) region is expected to experience the fastest growing region Global Neonatal Intensive Care Respiratory Devices Market, driven by rapidly developing economies in the region are leading to increased healthcare spending and substantial investments in enhancing neonatal care infrastructure.

This economic progress translates into a growing demand for advanced respiratory devices in neonatal intensive care units (NICUs).

Coupled with rising birth rates and an increasing number of preterm births, there is a larger patient pool requiring specialized respiratory support. This demographic trend underscores the critical need for effective neonatal respiratory care solutions.

Government initiatives across many APAC countries are prioritizing maternal and child healthcare improvements.

These initiatives include allocating funds to upgrade NICUs and equip them with essential respiratory devices, reflecting a strong commitment to improving neonatal outcomes. Such government support not only enhances the quality of care but also boosts the demand for advanced medical technologies.

While there is a growing market for high-end respiratory devices, affordability remains a crucial concern in many APAC countries. This creates a dual market dynamic where there is significant demand for both premium and cost-effective respiratory devices.

Manufacturers are thus incentivized to develop and offer a range of products that cater to diverse economic segments, ensuring broader access to life-saving technologies.

Market dynamics in the APAC region are also influenced by a surge in domestic production of neonatal respiratory devices. Factors such as lower manufacturing costs and a focus on self-reliance are driving this trend.

Domestic production not only meets local demand more efficiently but also supports regional economic growth and innovation.

Additionally, there is an increasing emphasis on early detection and intervention of neonatal respiratory problems. This proactive approach leads to a greater need for advanced and effective respiratory support technologies.

Early detection devices and interventions are essential in managing respiratory distress promptly, improving survival rates, and reducing long-term health complications for newborns.

Collectively, these factors are shaping a vibrant and rapidly expanding neonatal respiratory devices market in the Asia Pacific region.

Global Neonatal Intensive Care Respiratory Devices Market: Segmentation Analysis

The Global Neonatal Intensive Care Respiratory Devices Market is segmented based on Device Type, End-User, And Geography.

Neonatal Intensive Care Respiratory Devices Market, By Device Type

• Nebulizers
• Inhalers
• Ventilators
• Continuous Positive Airway Devices
• Apnea Monitors

Based on Device Type, the Neonatal Intensive Care Respiratory Devices Market is segmented into Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Devices, and Apnea Monitors. The Inhalers segment is experiencing significant growth in the Global Neonatal Intensive Care Respiratory Devices Market, owing to the increasing incidence of severe respiratory cases linked to extreme pollution levels. As pollution continues to escalate worldwide, leading to a gradual decline in the Air Quality Index, the demand for inhalers is expected to rise. This sector is anticipated to record higher sales in the coming years as healthcare providers seek effective solutions to manage and treat respiratory conditions in neonates affected by poor air quality.

Neonatal Intensive Care Respiratory Devices Market, By End-User

• NICU Hospitals
• Specialty Clinics
• Nursing Homes

Based on End-User, the Neonatal Intensive Care Respiratory Devices Market is segmented into NICU Hospitals, Specialty Clinics, and Nursing Homes. The NICU Hospitals segment is showing significant growth in the Global Neonatal Intensive Care Respiratory Devices Market owing to the increase in the number of premature births occurring in recent times. Owing to the number of premature births, the need for NICU facilities is becoming inevitable most of the time. It is further expected to expand.

Neonatal Intensive Care Respiratory Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Regional Analysis, the Global Neonatal Intensive Care Respiratory Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is substantially dominating the Global Neonatal Intensive Care Respiratory Devices Market and is expected to continue its dominance throughout the forecast period. North America is a leader in the neonatal respiratory devices market, thanks to its advanced healthcare infrastructure, which includes a high concentration of specialized neonatal intensive care units (NICUs) equipped with cutting-edge respiratory devices. The region experiences a relatively high rate of preterm births, which significantly increases the demand for respiratory support for neonates. Efforts to prevent preterm births are ongoing, yet advancements in neonatal care have notably improved the survival rates of premature infants, further necessitating the need for sophisticated respiratory aid.

Key Players

The "Global Neonatal Intensive Care Respiratory Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Getinge AB, GE Healthcare, Vyaire Medical Inc. (BD), Teleflex Incorporated, Medtronic plc, Mercury Medical, Dragerwerk AG & Co. KGaA, Dickinson & Company, Inspiration Healthcare Group plc, and Trudell Medical International. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Global Neonatal Intensive Care Respiratory Devices Market Key Developments

• In June 2020, Inspiration Healthcare plc paid £18 million to SLE, a provider of newborn ventilation products, following a successful funding round.
• In April 2020, during the COVID-19 pandemic, Philips debuted its readily available ventilation option, the Philips Respironics E30 ventilator. It would benefit clinics and hospitals that do not have critical care, full-featured ventilators.
• In April 2019, InnAccel announced SAANS, the world's first portable, infrastructure-independent newborn CPAP machine. It will aid critically unwell infants with RDS by providing breathing support.
• In April 2019, Dragerwerk AG & Co. KGaA gained FDA approval for the Seattle Positive Airway Pressure Plus System for neonates with respiratory distress syndrome.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY DEVICE TYPE

• 5.1 Overview
• 5.2 Nebulizers
• 5.3 Inhalers
• 5.4 Ventilators
• 5.5 Continuous Positive Airway Devices
• 5.5 Apnea Monitors
• 5.6 Others

6 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY END-USER

• 6.1 Overview
• 6.2 NICU Hospitals
• 6.3 Specialty Clinics
• 6.4 Nursing Homes
• 6.5 Other

7 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Getinge AB
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Business Breakdown
  • 9.1.4 Product Benchmarking
  • 9.1.5 Key Developments
  • 9.1.6 Winning Imperatives
  • 9.1.7 Current Focus & Strategies
  • 9.1.8 Threat from Competition
  • 9.1.9 SWOT Analysis
• 9.2 GE Healthcare
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Business Breakdown
  • 9.2.4 Product Benchmarking
  • 9.2.5 Key Developments
  • 9.2.6 Winning Imperatives
  • 9.2.7 Current Focus & Strategies
  • 9.2.8 Threat from Competition
  • 9.2.9 SWOT Analysis
• 9.3 Vyaire Medical Inc. (BD)
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Business Breakdown
  • 9.3.4 Product Benchmarking
  • 9.3.5 Key Developments
  • 9.3.6 Winning Imperatives
  • 9.3.7 Current Focus & Strategies
  • 9.3.8 Threat from Competition
  • 9.3.9 SWOT Analysis
• 9.4 Teleflex Incorporated
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Business Breakdown
  • 9.4.4 Product Benchmarking
  • 9.4.5 Key Developments
  • 9.4.6 Winning Imperatives
  • 9.4.7 Current Focus & Strategies
  • 9.4.8 Threat from Competition
  • 9.4.9 SWOT Analysis
• 9.5 Medtronic plc
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Business Breakdown
  • 9.5.4 Product Benchmarking
  • 9.5.5 Key Developments
  • 9.5.6 Winning Imperatives
  • 9.5.7 Current Focus & Strategies
  • 9.5.8 Threat from Competition
  • 9.5.9 SWOT Analysis
• 9.6 Mercury Medical
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Business Breakdown
  • 9.6.4 Product Benchmarking
  • 9.6.5 Key Developments
  • 9.6.6 Winning Imperatives
  • 9.6.7 Current Focus & Strategies
  • 9.6.8 Threat from Competition
  • 9.6.9 SWOT Analysis
• 9.7 Dragerwerk AG & Co. KGaA,
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Business Breakdown
  • 9.7.4 Product Benchmarking
  • 9.7.5 Key Developments
  • 9.7.6 Winning Imperatives
  • 9.7.7 Current Focus & Strategies
  • 9.7.8 Threat from Competition
  • 9.7.9 SWOT Analysis
• 9.8 Dickinson & Company
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Business Breakdown
  • 9.8.4 Product Benchmarking
  • 9.8.5 Key Developments
  • 9.8.6 Winning Imperatives
  • 9.8.7 Current Focus & Strategies
  • 9.8.8 Threat from Competition
  • 9.8.9 SWOT Analysis
• 9.9 Inspiration Healthcare Group plc
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Business Breakdown
  • 9.9.4 Product Benchmarking
  • 9.9.5 Key Developments
  • 9.9.6 Winning Imperatives
  • 9.9.7 Current Focus & Strategies
  • 9.9.8 Threat from Competition
  • 9.9.9 SWOT Analysis
• 9.10 Trudell Medical International
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Business Breakdown
  • 9.10.4 Product Benchmarking
  • 9.10.5 Key Developments
  • 9.10.6 Winning Imperatives
  • 9.10.7 Current Focus & Strategies
  • 9.10.8 Threat from Competition
  • 9.10.9 SWOT Analysis

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research